289 related articles for article (PubMed ID: 9844069)
1. Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children.
Kato S; Ritsuno H; Ohnuma K; Iinuma K; Sugiyama T; Asaka M
Helicobacter; 1998 Dec; 3(4):278-82. PubMed ID: 9844069
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
Louw JA; Van Rensburg CJ; Moola S; Kotze D; Marks IN
Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
[TBL] [Abstract][Full Text] [Related]
3. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
4. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
[TBL] [Abstract][Full Text] [Related]
5. Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing.
Louw JA; van Rensburg CJ; Hanslo D; Grundlings HD; Girdwood AH; Marks IN
Aliment Pharmacol Ther; 1998 Jun; 12(6):545-50. PubMed ID: 9678814
[TBL] [Abstract][Full Text] [Related]
6. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
[TBL] [Abstract][Full Text] [Related]
7. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
Ahuja V; Dhar A; Bal C; Sharma MP
Aliment Pharmacol Ther; 1998 Jun; 12(6):551-5. PubMed ID: 9678815
[TBL] [Abstract][Full Text] [Related]
8. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.
Harris AW; Misiewicz JJ; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D
Aliment Pharmacol Ther; 1998 Aug; 12(8):741-5. PubMed ID: 9726387
[TBL] [Abstract][Full Text] [Related]
9. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
10. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
Shashidhar H; Peters J; Lin CH; Rabah R; Thomas R; Tolia V
J Pediatr Gastroenterol Nutr; 2000 Mar; 30(3):276-82. PubMed ID: 10749411
[TBL] [Abstract][Full Text] [Related]
11. Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study).
Di Mario F; Battaglia F; Dal Bò N; Leandro G; Benedetti E; Bottona E; Caroli A; Costan-Biedo F; De Bastiani R; Germanà B; Andrea Grassi S; Madia D; Marcon V; Marin R; Monica F; Olivieri P; Orzes N; Pilotto A; Ronzani G; Saggioro A; Tafner G
Dig Liver Dis; 2000 Mar; 32(2):108-15. PubMed ID: 10975783
[TBL] [Abstract][Full Text] [Related]
12. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
Lamouliatte H; Perie F; Joubert-Collin M
Gastroenterol Clin Biol; 2000 May; 24(5):495-500. PubMed ID: 10891736
[TBL] [Abstract][Full Text] [Related]
14. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
[TBL] [Abstract][Full Text] [Related]
15. CagA status and Helicobacter pylori eradication among dyspeptic patients.
Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Harford W; Lanza F; Arora A; Graham D; Haber M; Weissfeld A; Rose P; Siepman N
Helicobacter; 1996 Dec; 1(4):243-50. PubMed ID: 9398875
[TBL] [Abstract][Full Text] [Related]
17. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
Luzza F; Giglio A; Ciliberto E; Belmonte A; Cavaliere C; Saccà N; Frandina C; Fiocca R; Trimboli V; Pallone F
Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734
[TBL] [Abstract][Full Text] [Related]
18. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group.
Wurzer H; Rodrigo L; Stamler D; Archambault A; Rokkas T; Skandalis N; Fedorak R; Bazzoli F; Hentschel E; Mora P; Archimandritis A; Megraud F
Aliment Pharmacol Ther; 1997 Oct; 11(5):943-52. PubMed ID: 9354205
[TBL] [Abstract][Full Text] [Related]
19. Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
Miki I; Aoyama N; Sakai T; Shirasaka D; Wambura CM; Maekawa S; Kuroda K; Tamura T; Kita T; Sakaeda T; Okumura K; Kasuga M
Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):27-33. PubMed ID: 12544691
[TBL] [Abstract][Full Text] [Related]
20. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Moshkowitz M; Konikoff FM; Peled Y; Brill S; Hallak A; Tiomny E; Santo M; Bujanover Y; Gilat T
Aliment Pharmacol Ther; 1996 Dec; 10(6):1015-9. PubMed ID: 8971304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]